LAGE3 promotes cell metastasis and stemness in non-small cell lung cancer companied with AKT/PI3K signaling pathway activation

被引:0
|
作者
Zhang, Heng [1 ,2 ]
Jian, Junling [1 ]
Chen, Hai [1 ]
Zhu, Xiaodong [1 ]
Xie, Jianfeng [1 ]
Xu, Xianquan [1 ]
机构
[1] Anhui Chest Hosp, Dept Thorac Surg, Hefei 230031, Anhui, Peoples R China
[2] Anhui Chest Hosp, Dept Thorac Surg, 397 Jixi Rd, Hefei 230022, Anhui, Peoples R China
关键词
NSCLC; LAGE3; AKT/PI3K; Cell proliferation; Migration and invasion; Stemness; EXPRESSION; DIAGNOSIS;
D O I
10.1016/j.prp.2023.154700
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Non-small cell lung cancer (NSCLC) is reported to have high mortality and morbidity rate worldwide. It is highly susceptible to metastasis. Previous reports have shown the L antigen family member 3 (LAGE3) expression in many cancers and has a carcinogenic role. However, the molecular mechanism of LAGE3 in NSCLC needs to be further explored.Methods: LAGE3 expression profile of NSCLC patients and normal samples in the TCGA cohort was utilized for visualization. Expression pattern of LAGE3 in cell lines of NSCLCs were determined through qRT-PCR. Further, transfection experiments was conducted to measure the LAGE3 & PRIME;s effect on the migration, proliferation, invasion, and stemness in NSCLC cell lines (A549 and H1975) by the assays of CCK-8, colony formation, EdU, transwell, and flow cytometry. The in vivo xenograft tumor growth in the nude mouse was conducted to confirm LAGE3 effect on NSCLC tumor growth. Furthermore, western blotting was applied to determine the levels of core proteins including AKT/PI3K signaling pathway and stemness proteins of Nanog, OCT4 and SOX2.Results: The TCGA based computational analysis showed that LAGE3 mRNA level in NSCLC was inter-related to worse overall survival. The up-regulated level of LAGE3 in NSCLC cell lines indicated its possibility as a future diagnostic and prognostic biomarker. Functional assays showed that cell migration, proliferation, invasion, sphere formation, and stemness-related protein (Nanog, SOX2, and OCT4) levels were significantly repressed by the knockdown of LAGE3. Subsequently, inhibition of LAGE3 in nude mice (in vivo) demonstrated its ability to reduce the tumor growth of NSCLC. The study also showed that LAGE3 knockdown suppressed cell progression by inactivating the signaling pathway of AKT/PI3K. Conclusions: LAGE3 could promote NSCLC development by activating the AKT/PI3K signaling pathway, thereby accelerating metastasis and cell stemness.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Overexpression of ELF3 facilitates cell growth and metastasis through PI3K/Akt and ERK signaling pathways in non-small cell lung cancer
    Wang, Hao
    Yu, Zhiqi
    Huo, Shaofen
    Chen, Zheng
    Ou, Zhiling
    Mai, Jiajie
    Ding, Shangwei
    Zhang, Jinshan
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2018, 94 : 98 - 106
  • [32] Clinicopathological significance of PTEN and PI3K/AKT signal transduction pathway in non-small cell lung cancer
    Yun, Fen
    Jia, Yongfeng
    Li, Xiuxia
    Yuan, Li
    Sun, Qinnuan
    Yu, Huiling
    Shi, Lin
    Yuan, Hongwei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2013, 6 (10): : 2112 - 2120
  • [33] SET Domain-Containing Protein 5 Enhances the Cell Stemness of Non-Small Cell Lung Cancer via the PI3K/Akt/mTOR Pathway
    Chen, Qing
    Sun, Zhuo
    Li, Jinfang
    Zhang, Donghua
    Guo, Bin
    Zhang, Tongwen
    JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY, 2021, 40 (02) : 55 - 63
  • [34] The activity of a PI3K δ-sparing inhibitor, MEN1611, in non-small cell lung cancer cells with constitutive activation of the PI3K/AKT/mTOR pathway
    Papoff, Giuliana
    Presutti, Dario
    Fustaino, Valentina
    Parente, Andrea
    Calandriello, Clelia
    Alema, Stefano
    Scavizzi, Ferdinando
    Raspa, Marcello
    Merlino, Giuseppe
    Salerno, Massimiliano
    Bigioni, Mario
    Binaschi, Monica
    Ruberti, Giovina
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [35] Nicotine promotes the development of non-small cell lung cancer through activating LINC00460 and PI3K/Akt signaling
    Zhao, Hongying
    Wang, Yu
    Ren, Xiubao
    BIOSCIENCE REPORTS, 2019, 39
  • [36] HDGF promotes gefitinib resistance by activating the PI3K/AKT and MEK/ERK signaling pathways in non-small cell lung cancer
    Han, Shuyan
    Tian, Zhihua
    Tian, Huifang
    Han, Haibo
    Zhao, Jun
    Jiao, Yanna
    Wang, Chunli
    Hao, Huifeng
    Wang, Shan
    Fu, Jialei
    Xue, Dong
    Sun, Hong
    Li, Pingping
    CELL DEATH DISCOVERY, 2023, 9 (01)
  • [37] The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling
    Dong-ming Wu
    Ting Zhang
    Ya-bin Liu
    Shi-hua Deng
    Rong Han
    Teng Liu
    Jing Li
    Ying Xu
    Cell Death & Disease, 10
  • [38] LPCAT1 Promotes Brain Metastasis of Non-Small Cell Lung Cancer Cells by Up-Regulating PI3K/AKT/MYC Pathway
    Wei, C.
    Lu, H.
    Dong, X.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1052 - S1052
  • [39] HDGF promotes gefitinib resistance by activating the PI3K/AKT and MEK/ERK signaling pathways in non-small cell lung cancer
    Shuyan Han
    Zhihua Tian
    Huifang Tian
    Haibo Han
    Jun Zhao
    Yanna Jiao
    Chunli Wang
    Huifeng Hao
    Shan Wang
    Jialei Fu
    Dong Xue
    Hong Sun
    Pingping Li
    Cell Death Discovery, 9
  • [40] FGF21 promotes non-small cell lung cancer progression by SIRT1/PI3K/AKT signaling
    Yu, Xiaofeng
    Li, Ying
    Jiang, Guodong
    Fang, Jian
    You, Zhaolei
    Shao, Guangyuan
    Zhang, Zheng
    Jiao, Aihong
    Peng, Xiaonu
    LIFE SCIENCES, 2021, 269